Key result
Eltanolone administered at /kg demonstrated a favorable pharmacokinetic profile with rapid total body clearance and trouble-free induction of anesthesia.
Why the study?
What are the pharmacokinetic and pharmacodynamic properties of the intravenous steroid anaesthetic eltanolone in healthy volunteers?
What are the pharmacokinetic and pharmacodynamic properties of the intravenous steroid anaesthetic eltanolone in healthy volunteers?
Eltanolone is a new steroid intravenous anaesthetic with a favorable pharmacokinetic profile characterized by rapid clearance and large distribution volumes.
Answers are grounded in this paper and cite their sources.
Favorable PK in volunteers supports patient trials; leaves open clinical role of eltanolone.
Eltanolone, a new intravenous steroid anaesthetic agent was administered intravenously in a dose of 0.6 mg.kg-1 over 45 s to eight healthy male volunteers to evaluate some of its pharmacokinetic and pharmacodynamic effects. Drug concentration-time data were analysed by PCNONLIN, a non-linear regression programme, showing data consistent with a three-compartment model with initial distribution half-life t1/2 lambda 1 between 0.3 and 2 min, intermediate distribution half-life t1/2 lambda 2 between 12 and 29 min and terminal half-life t1/2 lambda z between 72 and 212 min. The total body clearance of eltanolone was rapid and with individual values in the range 1.6-2.3 l.h-1.kg-1. Eltanolone was initially distributed into a relatively large central compartment V1 between 0.09 and 0.98 l.kg-1 and then extensively further distributed (Vss between 1.80 and 5.44 l.kg-1 and V between 4.87 and 11.87 l.kg-1). The excretion of unchanged of eltanolone in urine was very small, the renal clearance was less than 0.5% of the total clearance. Induction of anaesthesia was trouble free with onset and duration of anaesthesia between 1-2 min and 6-13 min, respectively. There was slight respiratory depression, a small transient increase in heart rate, and a maximum reduction in arterial blood pressure of 23%, as compared with the resting level. Pain on injection and venous sequelae were not seen. Involuntary movements were seen in one subject. We conclude that eltanolone has a favourable pharmacokinetic profile with relatively rapid half-lives, large distribution volumes and rapid total body clearance.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Carl et al. (1994) studied Healthy volunteers (n=8). Eltanolone was evaluated on Pharmacokinetic and pharmacodynamic effects. Eltanolone administered at /kg demonstrated a favorable pharmacokinetic profile with rapid total body clearance and trouble-free induction of anesthesia.
Synapse has enriched 10 related papers. Consider them for comparative context: